NASDAQ · IMTX
Immatics N.V.
Healthcare · Biotechnology
$7.73
Down-$0.23 (-2.98%)
Updated Oct 6, 2026, 11:49 PM
SID Score
3.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.22B
- P/E ratio
- -8.99
- Dividend yield
- 0.00%
- 52-week range
- $7.40 – $12.41
- Volume
- 554.12K
- Avg. volume
- 800.14K
Price performance · IMTX
IMTX price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 5, 2026
IMTX closed at $7.73 after 20 trading sessions, down 18.11% for the selected period.
- Last close
- $7.73
- Period change
- -18.11%
- Period low
- $7.59
- Period high
- $9.44
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 5, 2026 | $7.57 | $7.85 | $7.47 | $7.73 | 554.12K |
| Oct 2, 2026 | $8.56 | $8.57 | $7.40 | $7.59 | 1.26M |
| Oct 1, 2026 | $8.72 | $8.845 | $8.43 | $8.44 | 639.73K |
| Sep 30, 2026 | $8.56 | $9.16 | $8.43 | $8.78 | 1.9M |
| Sep 29, 2026 | $8.50 | $8.695 | $8.3901 | $8.56 | 644.38K |
| Sep 28, 2026 | $8.35 | $8.59 | $8.20 | $8.50 | 1.47M |
| Sep 25, 2026 | $8.39 | $8.50 | $8.25 | $8.37 | 378.84K |
| Sep 24, 2026 | $8.52 | $8.571 | $8.06 | $8.33 | 2.37M |
| Sep 23, 2026 | $8.80 | $8.89 | $8.575 | $8.60 | 384.17K |
| Sep 22, 2026 | $8.77 | $8.89 | $8.71 | $8.87 | 501.6K |
| Sep 21, 2026 | $8.76 | $8.87 | $8.58 | $8.72 | 305.4K |
| Sep 18, 2026 | $8.76 | $8.855 | $8.48 | $8.62 | 759.92K |
| Sep 17, 2026 | $8.97 | $9.04 | $8.74 | $8.82 | 427.73K |
| Sep 16, 2026 | $8.65 | $8.88 | $8.545 | $8.64 | 711.88K |
| Sep 15, 2026 | $8.59 | $8.77 | $8.335 | $8.60 | 355.79K |
| Sep 14, 2026 | $8.80 | $8.806 | $8.59 | $8.62 | 378.59K |
| Sep 11, 2026 | $8.84 | $8.921 | $8.535 | $8.79 | 527.25K |
| Sep 10, 2026 | $9.02 | $9.09 | $8.655 | $8.75 | 798.77K |
| Sep 9, 2026 | $9.38 | $9.555 | $9.085 | $9.11 | 326.08K |
| Sep 8, 2026 | $9.37 | $9.515 | $9.31 | $9.44 | 699.52K |
Latest IMTX news
The latest Smart Investors Daily articles mentioning IMTX.
Stock researchMarket Activity · Options
Company
Market Activity
Research & News

